La cadena de opciones muestra datos clave de las opciones de acciones de BioNexus Gene Lab a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para BioNexus Gene Lab..

BioNexus Gene Lab (NASDAQ:BGLC) Bolsa, Cadena de Opciones

BioNexus Gene Lab

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

BioNexus Gene Lab Corp

Lantmännen will invest more than 100 million euros in a state-of–the-art <a href="https://www.globenewswire.com/Tracker?data=D-7Y-KVbP6QZknfadXEZ-FyiOL801tmcb6MoPLIt1GBtRzzMxYqB5y0WMAfkDOuP8wF9RdBMPWvDS7IIKC_OkWudCUCt9vi-8ARGYU9fdadf5aFadydlfMoC2c0oEek0wq9shl6f0tFxH4iEsBbG2plhHfhgHB7WME97-NbSZIM6dfFRmaj3AkU_gZXrXeRD6wSfFlbL5NZEKQdFWd05Ix8BUt1dMN_MHpAiD0GLnSSve8knOhEkT3alPDLqD0Z4qqemEbKkxRZ3MJ3oKFuKXBYY26VDZ92n-tTgubAPhQo=">factory in Sweden</a>, while partnering with Ingredion to develop a differentiated portfolio of plant-based protein isolates based on yellow peas. Construction of the production plant will be completed in 2027.

News

INGR

Reported Earlier, Ingredion And Lantmännen Forge Strategic Alliance To Boost European Plant-Based Protein Market, Invest Over €100M In New Pea Protein Facility

Macro Economic Events

Econ #s

Economics

U.K. Trade Balance Non-EU For September -5.31B Vs. -4.85B (Revised) Prior

U.K. Trade Balance For September -16.32B Vs. -15.70B Est.; -15.21B (Revised) Prior

U.K. Monthly Gross Domestic Product (GDP) 3M/3M Change For September 0.1% Vs. 0.2% Est.; 0.2% Prior

U.K. Manufacturing Production (MoM) For September -1.0% Vs. 0.0% Est.; 1.3% (Revised) Prior

U.K. Industrial Production (MoM) For September -0.5% Vs. 0.1% Est.; 0.5% Prior

U.K. Gross Domestic Product (QoQ) Preliminary For Q3 0.1% Vs. 0.2% Est.; 0.5% Prior

U.K. Gross Domestic Product (YoY) Preliminary For Q3 1.0% Vs. 0.1% Est.; 0.7% Prior

U.K. Gross Domestic Product (MoM) For September -0.1% Vs. 0.2% Est.; 0.2% Prior

U.K. Business Investment (QoQ) Preliminary For Q3 1.2% Vs. 0.6% Est.; 1.4% Prior

Billionaire investor David Tepper&#8216;s Appaloosa Management reduced its stake in Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) by 5% in the third quarter, despite his recent public enthusiasm for Chinese investments, according to regulatory filings released Thursday.
What Happened: The reduction comes just months after Tepper declared that he <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41050711/stocks-rise-as-china-signals-more-stimulus-billionaire-david-tepper-bets-big-on-everythi">would buy &#8220;everything&#8221; China-related</a> amid Beijing&#8217;s stimulus efforts. Despite the trim, Alibaba remains Appaloosa&#8217;s largest holding, representing 15.75% of its $6.7 billion equity portfolio.
The hedge fund&#8217;s third-quarter moves reveal a complex strategy toward Chinese investments. While reducing positions in the iShares China Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>), KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>), and Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), Tepper more than doubled his stake in PDD Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) and increased positions in JD.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) and KE Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>).
The filing also revealed significant reductions in major U.S. technology holdings. Appaloosa sold 275,000 shares of Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), representing an 8.59% reduction while cutting its Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) position by 211,356 shares, or 21.89%. The fund also reduced its stake in Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) by 310,000 shares, a 49.6% decrease, and trimmed its position in Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>).
See Also: <a href="https://www.benzinga.com/news/global/24/11/41998381/tesla-earnings-will-be-hit-hardest-if-7500-ev-credit-is-cut-warns-gary-black-citing-80-dependence-on-ev-sales-please-do-the-math">Tesla Earnings Will Be Hit Hardest If $7.5K EV Credit Gets Cut By Trump, Warns Gary Black: &#8216;Do The Math&#8217;</a>
Why It Matters: Overall, Tepper&#8217;s exposure to Chinese stocks and ETFs increased to 38% of his equity portfolio in the third quarter, up from 26% in the previous quarter. This positions him, alongside Scion Asset Management&#8216;s Michael Burry, as one of the few prominent hedge fund managers <a href="https://www.benzinga.com/markets/equities/24/10/41248334/big-short-investor-michael-burrys-china-bet-pays-off-as-top-picks-surge-nearly-60-in-2-months">maintaining significant Chinese market exposure</a>. 
These portfolio adjustments come as Chinese stocks face headwinds from disappointing fiscal policies and persistent economic challenges, including weak consumer spending and an unstable property market. Market observers note that geopolitical tensions and potential tariff increases add further <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41902202/trumps-china-hawks-rumored-for-top-roles-yuan-hits-3-month-low">uncertainty to the investment landscape</a>.
The details of these transactions were disclosed in a Form 13F filing, a quarterly report required by the Securities and Exchange Commission for institutional investment managers overseeing more than $100 million in qualifying securities.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/41998258/cathie-wood-keeps-betting-on-amazons-haul-play-ark-loads-up-6m-worth-of-shares">Cathie Wood Keeps Betting On Amazon&#8217;s &#8216;Haul&#8217; Play: Ark Loads Up $6M Worth Of Shares</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Asia

Equities

Markets

ETFs

AMZN

BABA

BEKE

BIDU

GOOG

KWEB

MSFT

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Billionaire David Tepper's China Puzzle: Appaloosa Cuts Alibaba Stake While Doubling Down On PDD

QUBT

Reported Earlier, Quantum Computing Secures $40M Through Registered Direct Offering, Pricing 16M Shares At $2.50 Each in At-the-Market Deal

Michael Saylor, CEO of MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), deemed the Donald Trump-led Republican triumph the &#8220;biggest&#8221; bullish catalyst for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) over the last four years.
What Happened: In an interview with CNBC on Thursday, Saylor said that the &#8220;red wave&#8221; has been &#8220;incredibly auspicious&#8221; for Bitcoin and the broader cryptocurrency industry.
The Bitcoin bull anticipated a friendlier SEC at the helm amid speculations of current chair Gary Gensler stepping aside.
&#8220;It&#8217;s very good for the cryptocurrency industry. We&#8217;re going to see a lot more pro-Bitcoin policies. We are going to see a digital assets framework. We are going to see an end to the war on crypto.,&#8221; Saylor predicted.
Don&#8217;t Miss:
<ul>
<li>Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence.</a></li>
<li>1 in 4 Americans own a share of Bitcoin according to NASDAQ — <a href="https://www.benzinga.com/money/binance-100">this platform touts returns as high as 12.5% APY and is giving $100 in welcome rewards if you sign up today.</a></li>
</ul>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&quot;The red wave is probably the biggest thing that has happened in the past four years for bitcoin&quot; &#8211; <a href="https://twitter.com/MicroStrategy?ref_src=twsrc%5Etfw">@MicroStrategy</a> founder &amp; chairman <a href="https://twitter.com/saylor?ref_src=twsrc%5Etfw">@saylor</a> on his crypto expectations under a second Trump presidency. <a href="https://t.co/9BYAYgLGe8">pic.twitter.com/9BYAYgLGe8</a>
&mdash; CNBCOvertime (@CNBCOvertime) <a href="https://twitter.com/CNBCOvertime/status/1857179737606459844?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
With the election uncertainty behind, Saylor also ruled out any major bearish events for Bitcoin in the foreseeable future.
&#8220;I am planning the $100,000 party, and I am thinking it is probably going to be New Year&#8217;s Eve at my house. So, I would be surprised if we don&#8217;t go through $100,000 in November or December,&#8221; Saylor said in a burst of enthusiasm.
See Also: Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a>
Why It Matters: Saylor&#8217;s bullish sentiment aligned with the ongoing success of his company&#8217;s publicly-traded stock. 
MicroStrategy&#8217;s shares hit a record high earlier this week, pushing the firm&#8217;s market valuation to $72.26 billion, a $50 billion increase since September 6. This gain <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41961419/bitcoin-proxy-microstrategy-added-more-to-its-market-cap-in-last-2-months-than-what-ford-is-worth-currently">surpassed the total capitalization</a> of Ford Motor Co. (F) and Cognizant Technology Solutions Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>).
The firm, known famously as Bitcoin&#8217;s biggest corporate holder, was sitting on unrealized profits of over $12.7 billion as of this writing, <a href="https://bitcointreasuries.net/" target="_blank" rel="noreferrer noopener">according&nbsp;</a>to data from bitcointreasuries.net.&nbsp;&nbsp;
The company&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41646462/michael-saylor-says-bitcoin-remedy-to-fix-unhealthy-balance-sheets-as-microstrategy-unveil" target="_blank" rel="noreferrer noopener">announced plans</a>&nbsp;to raise as much as $42 billion in equity and debt funding over the next three years to accumulate more Bitcoin.
Price Action: At the time of writing, Bitcoin was exchanging hands at $88,121.00, down 1.89% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>. Shares of MicroStrategy closed 0.22% lower at $327.67 during Thursday&#8217;s regular trading session.
Photo Courtesy: Wikimedia
Read Next: 
<ul>
<li>This well known prop trading firm is offering 100% of your first $25,000 profit per account and 90% after that. <a href="https://www.benzinga.com/money/apex-trader-funding">Here's how to get a special 50% OFF CODE that lets you start out with monthly investments as low as $147 today.</a></li>
<li>If you invested $100 in DOGE when Elon Musk first tweeted about it in 2019,<a href="https://www.benzinga.com/money/etoro-doge"> here&#8217;s how much you&#8217;d have today</a>.</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

CTSH

MSTR

Michael Saylor Is Planning A Bitcoin $100K Party At His House, Expects End Of War On Crypto Under Trump

AGAE

Reported Earlier, AGAE Responds To Knighted's Legal Claims, Alleging Roy Choi's Attempt To Undermine Board's Strategic Decisions For Short-Term Gains

Elon Musk&#8216;s SpaceX has been increasing its launch cadence, enabling 17 launches in the last 31 days, and exceeding its <a href="https://www.benzinga.com/news/24/01/36860379/one-month-into-2024-spacex-is-already-falling-short-of-its-own-launch-targets-temporary-setback-or-c">monthly launch targets</a>.
What Happened: SpaceX&#8217;s Falcon 9 rocket launched 24 Starlink satellites to low-Earth orbit from Florida on Thursday, marking its 17th launch in 31 days.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Falcon 9 lifts off from pad 40 in Florida, completing our 17th launch in 31 days! <a href="https://t.co/w0snRDcUA9">pic.twitter.com/w0snRDcUA9</a>
&mdash; SpaceX (@SpaceX) <a href="https://twitter.com/SpaceX/status/1857082099154456924?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
SpaceX launched almost every other day in the last 31 days, exceeding its target set at the start of the year of 12 launches every month. 
However, the Musk-led space giant <a href="https://www.benzinga.com/news/24/07/39612042/elon-musks-spacex-launches-67-missions-in-first-half-of-2024-trailing-own-targets">fell short of its launch targets</a> in the first half of 2024, completing just 67 missions, not including its Starship test flights. The company is now trying to reach its launch target for the whole year by amping up launches in the remaining months.
Why It Matters: SpaceX has already exceeded 100 launches this year, outrunning its 96 launches in 2023. 
SpaceX VP of Launch Kiko Dontchev said earlier this month that the company will <a href="https://www.benzinga.com/news/24/11/41767169/spacex-completes-400th-successful-falcon-launch-to-date-but-will-miss-target-of-144-launches-in-2024">not make its goal of 144 launches this year</a> but is still targeting 30 more launches, or one launch every two days, for the rest of the year.
SpaceX is currently using its Falcon launch vehicles for the payload carrying missions. The company is also testing its Starship launch vehicle, whose next test flight is expected <a href="https://www.benzinga.com/general/space/24/11/41871398/spacex-aims-to-launch-starship-once-every-2-weeks-by-late-2025-ceo-elon-musk-says-we-will-be-much-faster">as early as Nov. 18</a>. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/partner/fintech/24/11/41939694/the-power-of-leverage-global-broker-octa-lays-out-the-ins-and-outs-of-this-trading-tool-for-trade">Ford Cuts Capri, Explorer EV Output Due To &#8216;Significantly Lower Than Expected Demand&#8217; After Pausing F-150 Lightning Production</a></li>
</ul>
Photo courtesy: SpaceX

SPACE

Tech

SpaceX Speeds Up Mission Launches With A New One Taking Off Every Other Day Over Last Month As It Races Towards Its 2024 Target

The Share Repurchase is being made pursuant to the Company's existing $50.0 million share repurchase program. On November 14, 2024, the Company announced that its Board of Directors authorized a share repurchase program, beginning on the date thereof and continuing through and including December 31, 2025. After the completion of the Share Repurchase described above, there will be $35.0 million remaining under the Company's share repurchase program.

Kodiak Gas Prices Upsized Offering Of 5.7M Common Shares At $34.50/Share; Proceeds To Selling Stockholder, $15M Buyback To Follow

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Thursday.
U.S. stocks settled lower on Thursday, with the Dow Jones falling more than 200 points during the session as investors digested recent economic reports.
U.S. initial jobless claims declined by 4,000 from the previous week to 217,000 in the week ending Nov. 9, compared to market estimates of 223,000. U.S. producer prices rose 0.2% month-over-month in October compared to a revised 0.1% gain in September, in line with market expectations.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell around 5.8% on Thursday after recording sharp gains in the recent period. The small-cap benchmark Russell 2000 tumbled over 1% during the session.
Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) shares fell over 2% on Thursday despite reporting better-than-expected results for its first quarter.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, industrials, and healthcare stocks recording the biggest losses on Thursday. However, information technology and energy stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 207 points to 43,750.86 on Thursday. The S&amp;P 500 fell 0.60% to 5,949.17, while the Nasdaq Composite fell 0.64% to close at 19,107.65 during Thursday's session.
Investors are awaiting earnings results from Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Spectrum Brands Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>), and RLX Technology Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 60.3, the index remained in the &#8220;Greed&#8221; zone on Thursday, versus a prior reading of 65.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41971544/jim-cramer-recommends-microsoft-praises-american-water-works-for-being-consistent">Jim Cramer Recommends Microsoft, Praises American Water Works For Being &#8216;Consistent&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Trading Ideas

CSCO

TSLA

Dow Dips Over 200 Points Following Economic Reports, Tesla Tumbles On Potential Removal Of EV Tax Credit: Fear Index Remains In 'Greed' Zone

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
<ul>
<li>Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity</li>
<li>More than 300,000 people in the US suffer from chronic spontaneous urticaria (CSU) that is inadequately controlled by antihistamines</li>
<li>FDA decision expected by April 18, 2025; if approved, Dupixent would be the first targeted therapy for CSU in a decade &nbsp;</li>
</ul>

REGN

Dupixent's sBLA Resubmission Accepted By FDA; Phase 3 Data Demonstrate Significant Itch And Hive Reduction For Chronic Urticaria Patients

Wing, a drone business backed by Google-parent Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and Apian, a British technology start-up, have launched a drone service for NHS blood sample deliveries in London.
What Happened:&nbsp;This new drone service, operating between Guy's and St Thomas' hospitals, reduces delivery time for blood samples from 30 minutes by van or motorbike to just 2 minutes, <a href="https://www.thetimes.com/article/dbd69ffe-252c-4d79-8f1f-ae9474f5b955">reported</a> The Times.
The drones are used to transport critical samples from patients at risk of bleeding disorders, helping to speed up decisions for surgeries and ensuring quick access to lab analysis.
Alphabet CEO Sundar Pichai took to X, formerly Twitter, and said, "Reducing blood sample delivery from 30 min to 2 min means faster results and quicker care for patients in critical need. Important use case for drone technology."
See Also:&nbsp;<a href="https://www.benzinga.com/tech/24/11/41894509/apples-next-big-bet-think-smaller-says-analyst-there-will-never-be-another-iphone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple&#8217;s Next Big Bet? Think Smaller, Says Analyst: &#8216;There Will Never Be Another… iPhone&#8217;</a>
Guy's and St Thomas' NHS Foundation Trust have also backed this venture.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Reducing blood sample delivery from 30 min to 2 min (!) means faster results and quicker care for patients in critical need. Important use case for drone technology &#8211; well done to <a href="https://twitter.com/Wing?ref_src=twsrc%5Etfw">@Wing</a> <a href="https://twitter.com/Apianaero?ref_src=twsrc%5Etfw">@apianaero</a> <a href="https://twitter.com/NHSuk?ref_src=twsrc%5Etfw">@NHSuk</a> <a href="https://t.co/BPANo3Gr00">https://t.co/BPANo3Gr00</a>
&mdash; Sundar Pichai (@sundarpichai) <a href="https://twitter.com/sundarpichai/status/1857120784713654611?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters:&nbsp;This initiative comes after Alphabet reported a 15% year-over-year increase in <a href="https://www.benzinga.com/news/earnings/24/10/41611263/alphabet-q3-earnings-highlights-revenue-beat-eps-beat-google-cloud-up-35-momentum-across-the-compan">third-quarter revenue</a>, highlighting the company&#8217;s extraordinary momentum.
The drone project also aligns with Alphabet&#8217;s previous ventures into drone delivery services, such as its partnership with DoorDash in the U.S. to deliver food items.
Apian, which identifies itself as a <a href="https://www.benzinga.com/general/24/04/38088421/doordash-partners-with-googles-wing-for-drone-delivery-pilot-in-the-us-to-fly-food-to-your-front-doo">&#8220;healthcare logistics&#8221; business</a>, aims to become the &#8220;Deliveroo of medical transport&#8221;,&nbsp;creating a platform to match&nbsp;clinicians with urgent transport requests&nbsp;and commercial drone companies.
The company&nbsp;was founded in 2020 by&nbsp;Dr. Christopher Law, Dr. Hammad Jeilani, and&nbsp;Alexander Trewby, formerly of Google&nbsp;Health.
Price Action: As of the latest data, Alphabet's Class A shares declined 0.24% in after-hours trading to $175.15, while Class C shares slipped 0.20% to $177. In the regular session on Thursday, Class A and Class C shares closed at $175.58 and $177.35, respectively, according to<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener"> Benzinga Pro data</a>.
World Economic Forum on Flickr
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/24/11/41927913/amazon-confirms-vendor-data-breach-affecting-2-8m-employee-contacts-adds-to-growing-list-of-moveit-hack-victims?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amazon Confirms Vendor Data Breach Affecting 2.8M+ Employee Contacts, Adds To Growing List Of MOVEit Hack Victims</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Health Care

Media

GOOGL

Sundar Pichai Praises Google-Backed Apian Drones For Cutting Blood Sample Delivery Time From 30 To 2 Minutes: 'Quicker Care For Patients In Critical Need'

<ul>
<li>Afqlir&#xAE; (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)</li>
<li>One of several biosimilar value drivers for Sandoz</li>
<li>Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing global and European leadership</li>
</ul>

SDZNY

SDZXF

Sandoz Gains European Commission Approval For Afqlir (aflibercept), Targeting Wider Access Biosimilars In Europe

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Friday is here and we&rsquo;re breaking down the biggest pre-market stock movers that traders need to know about this morning!



Moving stocks this morning are shareholder meetings, earnings reports, a dividend and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwodu-stock-quote/">RWODU</a>) stock is rocketing more than 84% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318243471&amp;type=PDF&amp;symbol=RWOD&amp;cdn=b571d8a48f5cf4a43db1e1aee09248ab&amp;companyName=Redwoods+Acquisition+Corp.&amp;formType=425&amp;formDescription=Prospectuses+and+communications%2C+business+combinations&amp;dateFiled=2024-04-18">details of a shareholder meeting</a>.</li>



<li>Zhongchao (NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) shares are soaring over 83% with heavy pre-market trading.</li>



<li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is also surging more than 69% on that shareholder meeting.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) shares are gaining over 33% with its <a href="https://www.nasdaq.com/press-release/wang-lee-group-inc.-announces-fiscal-year-2023-financial-results-2024-04-18">2023 earnings report</a>.</li>



<li>Next e GO (NASDAQ:<a href="https://investorplace.com/stock-quotes/egox-stock-quote/">EGOX</a>) stock is increasing more than 23% on strong early morning trading.</li>



<li>Ault Alliance (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ault-stock-quote/">AULT</a>) shares are rising over 23% after <a href="https://finance.yahoo.com/news/ault-alliance-declares-monthly-cash-103000927.html">announcing a cash dividend</a>.</li>



<li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is climbing more than 23% with heavy trading this morning.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are jumping close to 22% as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318243734&amp;type=PDF&amp;symbol=TPET&amp;cdn=802b738c707aac03352a0b144f6bbbb7&amp;companyName=Trio+Petroleum+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-19">plans for an annual shareholder meeting</a>.</li>



<li>Richtech Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rr-stock-quote/">RR</a>) stock is getting an over 20% boost despite a lack of news this morning.</li>



<li>Centogene (NASDAQ:<a href="https://investorplace.com/stock-quotes/cntg-stock-quote/">CNTG</a>) shares are up more than 19% without any apparent news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Tritium DCFC (NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock is crashing over 61% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318241881&amp;type=PDF&amp;symbol=DCFC&amp;cdn=21bc4c0fb2af1dc1e7b76f221263a80e&amp;companyName=Tritium+DCFC+Limited&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-18">warning of insolvency</a>.</li>



<li>BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) shares are plummeting more than 23% following a <a href="https://www.nasdaq.com/press-release/bionexus-gene-lab-corp.-agrees-to-invest-rm-1.2-million-in-ascension-innovation-aisb">rally late yesterday</a>.</li>



<li>Tian Ruixiang (NASDAQ:<a href="https://investorplace.com/stock-quotes/tirx-stock-quote/">TIRX</a>) stock is diving over 18% after a <a href="https://investorplace.com/2024/04/why-is-tian-ruixiang-tirx-stock-up-209-today/">massive rally yesterday</a>.</li>



<li>iSpecimen (NASDAQ:<a href="https://investorplace.com/stock-quotes/ispc-stock-quote/">ISPC</a>) shares are tumbling more than 17% after a major rally on Thursday.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is taking an over 17% beating on Friday morning.</li>



<li>Sunshine Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/sbfm-stock-quote/">SBFM</a>) shares are falling more than 16% this morning.</li>



<li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is dropping nearly 16% with its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318243156&amp;type=PDF&amp;symbol=MLEC&amp;cdn=8dae77192b72d42d8942b9dec934f931&amp;companyName=Moolec+Science+SA&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-18">latest earnings release</a>.</li>



<li>AGBA Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) shares are retreating over 15% after <a href="https://investorplace.com/2024/04/why-is-agba-group-agba-stock-up-149-today/">soaring yesterday on merger plans</a>.</li>



<li>MariaDB (NYSE:<a href="https://investorplace.com/stock-quotes/mrdb-stock-quote/">MRDB</a>) stock is decreasing more than 13% this morning.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) shares close out our pre-market stock movers down over 13% after <a href="https://investorplace.com/2024/04/why-is-invo-bioscience-invo-stock-up-85-today/">a recent rally</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-april-19th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) stock is falling on Friday but investors will note that this comes after its shares underwent a rally late on Thursday.



BioNexus Gene Lab shares closed out Thursday up 28.8% with about 3.1 million units traded. That was more than its daily average trading volume of about 1.6 million shares.



The catalyst for this rally was BioNexus Gene Lab announcing its agreement to <a href="https://www.nasdaq.com/press-release/bionexus-gene-lab-corp.-agrees-to-invest-rm-1.2-million-in-ascension-innovation-aisb">invest $250,000 in Ascension Innovation</a>. This is a privately held Malaysian company focused on advancing digital health information with artificial intelligence (<a href="https://investorplace.com/stock-quotes/ai-stock-quote/">AI</a>).



Sam Tan, CEO, BioNexus Gene Lab, said this about the news.




&ldquo;Our investment in AISB reflects our belief in their transformative healthcare solutions. Together, we aim to revolutionize patient care through predictive and generative AI.&rdquo;




AI has been a hot topic lately with news of it often raising a company&rsquo;s shares. Yesterday&rsquo;s gains were likely the result of traders flocking to BGLC stock due to the AI connection with this investment.



<h2>BGLC Stock Movement on Friday</h2>



Unfortunately, it doesn&rsquo;t look like BGLC is able to maintain the positive movement it saw yesterday. This has the stock down 26.8% during pre-market hours on Friday. However, this doesn&rsquo;t come with heavy trading as only around 66,000 units have changed hands this morning.



Investors will see even more of the latest stock market stories below!



We have all of the hottest market news traders need to know about on Friday! That includes everything happening with shares of Tritium DCFC&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock, Zhongchao&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/">ZCMD</a>) stock and Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock today. You can catch up on all of these matters at the following links!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-tritium-dcfc-dcfc-stock-down-63-today/">Why Is Tritium DCFC (DCFC) Stock Down 63% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-zhongchao-zcmd-stock-up-103-today/">Why Is Zhongchao (ZCMD) Stock Up 103% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is in the news Friday as after the special purpose acquisition company (SPAC) got <a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">approval from shareholders</a> for its merger with Anew Medical.



Let&rsquo;s get into everything traders need to know about the SPAC merger between Redwoods Acquisition and Anew Medical below!



<h2>RWOD Stock SPAC Merger Details</h2>



<ul><li>Redwoods Acquisition and Anew Medical first <a href="https://www.biospace.com/article/releases/anew-medical-announces-key-patent-issued-in-china-to-protect-klotho-protein-and-gene-delivery-systems/#:~:text=In%20May%202023%2C%20ANEW%20announced,to%20be%20listed%20on%20NASDAQ">entered into this merger agreement</a> in May 2023 with plans for ANEW stock to start trading in March 2024.</li>



<li>While there&rsquo;s been a slight delay to that this latest shareholder vote paves the way for Anew Medical to take over the combined company once the merger is complete.</li>



<li>When the two companies combine they will focus on Anew Medical&rsquo;s goals.</li>



<li>The <a href="https://www.anewmeds.com/">company is focused on the</a> &ldquo;development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.&rdquo;</li>



<li>This will have it further develop its &aacute;-Klotho gene therapy research programs.</li>



<li>Anew Medical also notes that it doesn&rsquo;t believe there&rsquo;s much competition in this space due to its strong intellectual property position.</li>



<li>Leading Anew Medical is Dr. Joseph Sinkule with 40 years of experience in the drug development, research and commercialization markets.</li>
</ul>RWOD stock is up 66.5% as of Friday morning with more than 4 million shares changing hands. That&rsquo;s well above its daily average trading volume of about 11,000 shares.



Investors will find more of the most recent stock market stories ready to go down below!



We have all of the hottest stock market news available on Friday! Among that is what has shares of Trump Media&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>), BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) and Tritium DCFC&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock moving today. All of that info is available below!



<h2>More Friday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/djt-stock-pops-as-trump-media-takes-on-short-sellers/">DJT Stock Pops as Trump Media Takes On Short Sellers</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-tritium-dcfc-dcfc-stock-down-63-today/">Why Is Tritium DCFC (DCFC) Stock Down 63% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/rwod-stock-7-things-to-know-about-the-anew-medical-merger/">RWOD Stock: 7 Things to Know About the Anew Medical Merger</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RWOD Stock: 7 Things to Know About the Anew Medical Merger

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Marathon Digital (NASDAQ:<a href="https://investorplace.com/stock-quotes/mara-stock-quote/">MARA</a>) stock is on the rise Friday as the Bitcoin (<a href="https://investorplace.com/cryptocurrency/btc-usd/">BTC-USD</a>) mining company prepares for the token&rsquo;s halving event.



That Bitcoin halving is expected to take place <a href="https://www.cnbc.com/2024/04/18/jpmorgan-likes-these-mining-stocks-to-play-the-upcoming-bitcoin-halving.html">either today or sometime tomorrow</a>. When this happens, the reward for mining BTC will be reduced. That&rsquo;s a big deal for MARA stock and other Bitcoin mining shares.



The pressure of the upcoming Bitcoin halving has been weighing on mining stocks but that might not be a bad thing. While this has MARA stock down 32.4% year-to-date, this weakness could make for an attractive entry point.



It also bears mentioning that Marathon Digital and other Bitcoin mining companies are <a href="https://investorplace.com/2024/04/why-marathon-digital-stock-is-worth-buying-ahead-of-the-bitcoin-halving/">better prepared for the halving</a> this time around. That has them ordering new miners, increasing electricity flows and taking other actions to prepare for the event.



<h2>What The Bitcoin Halving Means for MARA Stock</h2>



One thing that traders in MARA will keep in mind is the effects of the Bitcoin halving. Experts are predicting that the event will send the token higher. That includes it surpassing its previous all-time high. This could be a major boon to BTC miners.



MARA stock is up 2.1% as of Friday morning with more than 12 million shares traded. That&rsquo;s still below its daily average trading volume of about 66 million shares.



Investors will find even more of the most recent stock market stories below!



We have all of the hottest stock market news investors need to know about on Friday! A few examples include what&rsquo;s happening with shares of Redwoods Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>), Trump Media&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) and BioNexus Gene Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) stock today. All of that news is available at the following links!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/04/rwod-stock-7-things-to-know-about-the-anew-medical-merger/">RWOD Stock: 7 Things to Know About the Anew Medical Merger</a></li>



<li><a href="https://investorplace.com/2024/04/djt-stock-pops-as-trump-media-takes-on-short-sellers/">DJT Stock Pops as Trump Media Takes On Short Sellers</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-bionexus-gene-lab-bglc-stock-down-27-today/">Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/mara-stock-alert-get-ready-for-the-bitcoin-halving/">MARA Stock Alert: Get Ready for the Bitcoin Halving</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MARA Stock Alert: Get Ready for the Bitcoin Halving

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the trading week with a breakdown of the biggest pre-market stock movers worth reading about on Monday!



Moving stocks are the assassination attempt on former President Donald Trump, new agreements and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>DatChat (NASDAQ:<a href="https://investorplace.com/stock-quotes/dats-stock-quote/">DATS</a>) stock is rocketing more than 122% following <a href="https://www.cnn.com/politics/live-news/trump-rally-shooting-07-14-24/index.html">the assassination attempt</a> on former President Donald Trump.</li>



<li>Trump Media &amp; Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) shares are soaring over 56% after the assassination attempt on the former President.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is surging more than 43% for those same reasons.</li>



<li>Pop Culture (NASDAQ:<a href="https://investorplace.com/stock-quotes/cpop-stock-quote/">CPOP</a>) shares are rising close to 38% alongside heavy pre-market trading.</li>



<li>Vince (NYSE:<a href="https://investorplace.com/stock-quotes/vnce-stock-quote/">VNCE</a>) stock is increasing over 23% without any news to report this morning.</li>



<li>Crown LNG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) shares are heading more than 18% higher with strong early morning trading today.</li>



<li>Valkyrie Bitcoin Futures Leveraged Strategy ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/btfx-stock-quote/">BTFX</a>) stock is climbing over 18% alongside a Bitcoin (<a href="https://investorplace.com/cryptocurrency/btc-usd/">BTC-USD</a>) rally</li>



<li>ProShares Trust ProShares Ultra Bitcoin ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/bitu-stock-quote/">BITU</a>) shares are gaining more than 17% for the same reason.</li>



<li>Universe Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/upc-stock-quote/">UPC</a>) stock is jumping over 15% without any clear news this morning.</li>



<li>ProShares Trust ProShares Ultra Ether ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/etht-stock-quote/">ETHT</a>) shares are up nearly 15% with a crypto rally.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is diving more than 25% without any clear news to report on Monday morning.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are tumbling over 23% <a href="https://investorplace.com/2024/07/why-is-qualigen-qlgn-stock-up-141-today/">after a recent rally</a>.</li>



<li>TDH (NASDAQ:<a href="https://investorplace.com/stock-quotes/petz-stock-quote/">PETZ</a>) stock is taking a more than 21% beating after a Friday rally.</li>



<li>Eastside Distilling (NASDAQ:<a href="https://investorplace.com/stock-quotes/east-stock-quote/">EAST</a>) shares are sliding over 21% despite a lack of news this morning.</li>



<li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is dropping more than 18% <a href="https://www.stocktitan.net/news/MLEC/moolec-signs-an-offtake-agreement-with-major-global-cpg-company-to-sfqwiqzywbga.html">after signing an offtake agreement</a>.</li>



<li>Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) shares are decreasing over 17% on Monday morning.</li>



<li>ProShares Trust ProShares UltraShort Bitcoin ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/sbit-stock-quote/">SBIT</a>) stock is falling more than 16% this morning.</li>



<li>Logistic Properties (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lpa-stock-quote/">LPA</a>) shares are slipping over 15% after <a href="https://www.nasdaq.com/press-release/logistic-properties-americas-expands-board-appointments-two-independent-directors">adding two new directors</a>.</li>



<li>Locafy (NASDAQ:<a href="https://investorplace.com/stock-quotes/lcfy-stock-quote/">LCFY</a>) stock is dipping more than 15% today.</li>



<li>BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) shares close out our pre-market stock movers down over 15% on Monday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) just reported results for the second quarter of 2024.<ul><li>BioNexus Gene Lab reported earnings per share of 1.1 cents.</li><li>The company reported revenue of $1.98 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/bglc-stock-earnings-bionexus-gene-lab-for-q2-of-2024/">BGLC Stock Earnings: BioNexus Gene Lab Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BGLC Stock Earnings: BioNexus Gene Lab Reported Results for Q2 2024

An announcement from BioNexus Gene Lab Corp (BGLC) is now available. BioNexus Gene Lab Corp. has strategically invested RM 1 million to acquire a s...

BioNexus Gene Lab's Strategic Investment in AI Healthcare

BioNexus Gene Lab Corp (BGLC) has shared an announcement. BioNexus Gene Lab Corp. announced a significant boost in confidence with a successful co-...

BioNexus Receives Government Backing for Healthcare Tech

BioNexus Gene Lab signs strategic partnership with Shenzhen Rongguang Group

BioNexus Gene Lab Corp ( ($BGLC) ) has issued an update. BioNexus Gene Lab Corp faces potential delisting from Nasdaq due to non-compliance with th...

BioNexus Gene Lab Faces Delisting and Leadership Changes

AGBA

AULT

BGLC

BITU

BTFX

CGBS

CNTG

CPOP

DCFC

EAST

EGOX

ETHT

GPAK

HUBC

INVO

ISPC

LCFY

LTRY

MARA

MLEC

MRDB

PETZ

PHUN

QLGN

RWOD

RWODU

SBFM

SBIT

SPEC

TIRX

TPET

VNCE

ZCMD

Opinion

Press Releases

Thinking about buying stock in BioNexus Gene Lab, Gladstone Investment Corp, Canopy Growth Corp, Recursion Pharmaceuticals, or Monolithic Power Systems?

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

Financing

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

General

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

GAIN

MPWR

RXRX

Alta Equipment Group Inc. Class A Common Stock

Alta Equipment Group

Baiyu Holdings

Euro Tech Holdings Company Limited - Ordinary Shares

Euro Tech Hldgs

EVI Industries

FGI Industries

Hudson Technologies

iPower

Karat Packaging

Multi Ways Holdings Limited Ordinary Shares

Multi Ways Holdings

Simpple

Titan Machinery

ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares

ZKH Group

Comments

BioNexus Gene Lab

BioNexus Gene Lab (BGLC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL